Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

TELA Bio (TELA) Shares Outstanding (2018 - 2026)

TELA Bio has reported Shares Outstanding over the past 8 years, most recently at $44.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 13.05% year-over-year to $44.5 million; the TTM value through Dec 2025 reached $44.5 million, up 13.05%, while the annual FY2025 figure was $44.5 million, 13.05% up from the prior year.
  • Shares Outstanding for Q4 2025 was $44.5 million at TELA Bio, up from $40.3 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $44.5 million in Q4 2025 and troughed at $14.4 million in Q1 2021.
  • A 5-year average of $24.8 million and a median of $24.5 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: grew 0.41% in 2021 and later skyrocketed 68.13% in 2023.
  • Year by year, Shares Outstanding stood at $14.5 million in 2021, then soared by 31.9% to $19.2 million in 2022, then grew by 27.81% to $24.5 million in 2023, then surged by 60.83% to $39.4 million in 2024, then grew by 13.05% to $44.5 million in 2025.
  • Business Quant data shows Shares Outstanding for TELA at $44.5 million in Q4 2025, $40.3 million in Q3 2025, and $39.6 million in Q2 2025.